Related Experiment Video
Updated: Oct 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Acute myocardial infarction and cardiogenic shock in patient with COVID-19]
Yu A Schneider1, V G Tsoi1, M S Fomenko1
1Federal Сenters of High Medical Technologies of Health Ministry, settl. Rodniki, Kaliningrad, Russia.
Insights
This case study highlights a successful treatment strategy for a patient with both COVID-19 and acute myocardial infarction (AMI). Intensive care and timely intervention, including extracorporeal membrane oxygenation, saved a life threatened by cardiogenic shock.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic has strained healthcare systems, complicating care for acute cardiovascular conditions like acute coronary syndrome (ACS).
- Co-infection with COVID-19 and acute myocardial infarction (AMI) presents a significantly elevated mortality risk.
- Managing patients with both critical conditions requires specialized strategies.
Observation:
- A 69-year-old patient presented with cardiogenic shock secondary to ACS, complete left bundle branch block, and severely reduced left ventricular ejection fraction (19%).
- The patient was concurrently diagnosed with COVID-19.
- This clinical scenario posed a severe threat to life due to the dual pathology.
Findings:
- Successful coronary angiography with stenting was performed under extracorporeal membrane oxygenation (ECMO) support.
- The patient underwent prolonged intensive care unit (ICU) therapy followed by cardiac surgery unit management.
- A gradual recovery was observed, leading to hospital discharge on day 56.
Implications:
- This case demonstrates the feasibility and effectiveness of an aggressive, multidisciplinary approach in managing complex COVID-19 and AMI cases.
- Intensive care and timely interventions, including ECMO and revascularization, are crucial for improving outcomes in critically ill patients.
- The described strategy offers a potential model for saving lives in similar high-risk patient populations.
Abstract:
The conditions of the pandemic caused by the novel coronavirus infection (COVID-19) are associated with overloading intensive care units, conversion of hospitals, and changes in routing of patients with acute cardiovascular pathology. At the same time, medical practice is still challenged to provide medical care to patients with acute coronary syndrome (ACS). Patients with COVID-19 and acute myocardial infarction (AMI) are at a higher risk of death while the incidence of this combination of diseases will be growing. This article describes a case of diagnosis and treatment of COVID-19 in a 69-year-old patient who was urgently hospitalized with cardiogenic shock associated with ACS, electrocardiographic signs of complete left bundle branch block, and left ventricular ejection fraction of 19 %. Coronary angiography with stenting was successfully performed in the conditions of extracorporeal membrane oxygenation. The patient received long-term intensive therapy in the intensive care unit followed by symptomatic treatment in the cardiac surgery unit. The patient's condition gradually improved and he was discharged from the hospital on the 56th day. The strategy of intensive care and active follow-up helped saving life of the patient with COVID-19 and AMI.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Introduction Cardiac Emergencies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...

